Serum NTX and urine α-CTX levels in breast cancer patients were all higher than the standard values, and very high urine α-CTX levels were detected in breast cancer patients with bone metastases (specificity:70%; sensitivity: 85%), suggesting that urinary α-CTX level is a particularly important diagnostic marker of breast cancer [55]. Here, CYP27A1 is linked to breast cancer.